참고문헌
- Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014;64:104-17. https://doi.org/10.3322/caac.21220
- Willett CG, Czito BG, Bendell JC. Radiation therapy in stage II and III rectal cancer. Clin Cancer Res 2007;13(22 Pt 2):6903s-8s. https://doi.org/10.1158/1078-0432.CCR-07-1158
- Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15. https://doi.org/10.1056/NEJM199103143241101
- Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000;92:388-96. https://doi.org/10.1093/jnci/92.5.388
- Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40. https://doi.org/10.1056/NEJMoa040694
- Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012;30:1926-33. https://doi.org/10.1200/JCO.2011.40.1836
- Kachnic LA. Should preoperative or postoperative therapy be administered in the management of rectal cancer? Semin Oncol 2006;33(6 Suppl 11):S64-9. https://doi.org/10.1053/j.seminoncol.2006.10.018
- Pasetto LM. Preoperative versus postoperative treatment for locally advanced rectal carcinoma. Future Oncol 2005;1:209-20. https://doi.org/10.1517/14796694.1.2.209
- Park JH, Yoon SM, Yu CS, Kim JH, Kim TW, Kim JC. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer. Cancer 2011;117:3703-12. https://doi.org/10.1002/cncr.25943
- Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009;27:5124-30. https://doi.org/10.1200/JCO.2009.22.0467
- van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomized controlled TME trial. Lancet Oncol 2011;12:575-82. https://doi.org/10.1016/S1470-2045(11)70097-3
- Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24:4620-5. https://doi.org/10.1200/JCO.2006.06.7629
- Collette L, Bosset JF, den Dulk M, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 2007;25:4379-86. https://doi.org/10.1200/JCO.2007.11.9685
- Peng LC, Milsom J, Garrett K, et al. Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer. Cancer Epidemiol 2014;38:73-8. https://doi.org/10.1016/j.canep.2013.12.008
- Marinello FG, Frasson M, Baguena G, et al. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary. Dis Colon Rectum 2015;58:556-65. https://doi.org/10.1097/DCR.0000000000000349
- Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009;373:811-20. https://doi.org/10.1016/S0140-6736(09)60484-0
- Lee JW, Lee JH, Kim JG, et al. Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis. Radiat Oncol J 2013;31:155-61. https://doi.org/10.3857/roj.2013.31.3.155
- Lee JH, Kim DY, Kim SH, et al. Carcinoembryonic antigen has prognostic value for tumor downstaging and recurrence in rectal cancer after preoperative chemoradiotherapy and curative surgery: a multi-institutional and case-matched control study of KROG 14-12. Radiother Oncol 2015;116:202-8. https://doi.org/10.1016/j.radonc.2015.07.049
- Song JH, Kim SH, Lee JH, et al. Significance of histologic tumor grade in rectal cancer treated with preoperative chemoradiotherapy followed by curative surgery: a multi-institutional retrospective study. Radiother Oncol 2016;118:387-92. https://doi.org/10.1016/j.radonc.2015.11.028
- Kwak YK, Kim K, Lee JH, et al. Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: a multi-institutional study for optimal surgical timing in rectal cancer. Radiother Oncol 2016;119:512-8. https://doi.org/10.1016/j.radonc.2016.03.017
피인용 문헌
- Current Trends in the Rate of Rectal Cancer Restorative Operations in the Era of Neoadjuvant Chemoradiation vol.14, pp.1, 2017, https://doi.org/10.1007/s11888-018-0400-2
- Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial vol.38, pp.None, 2018, https://doi.org/10.1186/s40880-018-0342-8
- Advances in Radiotherapy for Locally Advanced Rectal Cancer vol.8, pp.1, 2018, https://doi.org/10.12677/acm.2018.81011
- Comparative survival analysis of preoperative and postoperative radiotherapy in stage II-III rectal cancer on the basis of long-term population data vol.8, pp.None, 2017, https://doi.org/10.1038/s41598-018-35493-2
- Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis vol.11, pp.None, 2017, https://doi.org/10.2147/cmar.s189445
- Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis vol.34, pp.1, 2019, https://doi.org/10.1007/s00384-018-3174-8
- MRI for Restaging Locally Advanced Rectal Cancer: Detailed Analysis of Discrepancies With the Pathologic Reference Standard vol.213, pp.5, 2019, https://doi.org/10.2214/ajr.19.21383
- Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: A Multicenter Comparative Cross-Sectional Study with Rectal Preservation as Supported by Surgeon vol.43, pp.12, 2017, https://doi.org/10.1007/s00268-019-05128-2
- Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer vol.52, pp.2, 2020, https://doi.org/10.4143/crt.2019.261
- Total Neoadjuvant Therapy for Rectal Cancer: Current Status and Future Directions vol.16, pp.6, 2017, https://doi.org/10.1007/s11888-020-00461-4
- Short-term outcomes of laparoscopic intersphincteric resection with intraoperative radiotherapy using low-energy X-rays for primary locally advanced low rectal cancer: a single center experience vol.18, pp.None, 2017, https://doi.org/10.1186/s12957-020-1799-x
- MRI-defined high-risk rectal cancer patients: outcome comparison between neoadjuvant chemoradiotherapy plus TME and TME plus adjuvant chemotherapy or TME alone vol.94, pp.1120, 2017, https://doi.org/10.1259/bjr.20201221
- Magnetic resonance imaging-radiomics evaluation of response to chemotherapy for synchronous liver metastasis of colorectal cancer vol.27, pp.38, 2017, https://doi.org/10.3748/wjg.v27.i38.6465